XML 56 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Securities Purchase Agreement (Details Textual) (USD $)
1 Months Ended 12 Months Ended
Mar. 31, 2011
May 31, 2010
Dec. 31, 2012
Agreement
Dec. 31, 2011
Mar. 03, 2012
Feb. 29, 2012
Feb. 17, 2012
Jan. 19, 2012
May 07, 2011
Apr. 14, 2011
May 26, 2010
Securities Purchase Agreement (Textual) [Abstract]                      
Preferred stock, par value       $ 0.0001              
Preferred stock, par value     $ 0.0001                
Embedded Derivatives of accrued dividends payable        $ 15,270,000              
Preferred stock, shares authorized     8,000,000                
Warrant, net proceeds     500,000                
Proceeds from warrants, shares     500                
Shares converted to common stock       123,000              
Reverse stock split ratio     100     0.0001 0.0001 100   0.0001  
Securities Purchase Agreement (Additional Textual) [Abstract]                      
Percentage of investment of proceeds contributed by employee maximum   3.00%                  
Proceeds from issuance of derivative obligations   6,003,000                  
Common stock, par value     $ 0.0001 $ 0.0001             $ 0.0001
Common stock, stated price                     $ 3.00
Proceeds from preferred stock per share                     $ 1,000
Exercise price series D1 warrants preferred   $ 1,000                  
Exercise price series C2 warrants preferred   1,000                  
Additional cash payment for right to receive Series C2 Preferred after milestones 236,000                    
Stockholders redemption period     12 months                
Preferred Stock holders waived their 12-month redemption right and the requirement for the company to keep net cash     2,900,000                
Expiration Period of warrants     3 years                
Initial conversion ratio of new preferred stock to common stock     6,667   213,083       166,667    
Amount paid upon exercise of redemption rights       5,116,000              
Preferred stock, liquidation preference price per share     $ 1,000                
Extended Termination Date     3 years                
Price per share of common stock discounted from the closing market prices       $ 0.27              
Number of times company and purchasers entered into amendment agreements     2                
Derivative liabilities        15,270,000              
Maximum [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Conversion Price Percentage     3.76%                
Minimum [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Minimum preferred stock outstanding if warrants are exercised     3,000                
Preferred stock, shares outstanding     1,000                
Ownership percentage     9.999%                
Conversion Price Percentage     0.00%                
Series C-2 Preferred Stock [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Preferred stock, shares authorized     22,000                
Preferred stock, shares issued     500                
Preferred stock, shares outstanding     500                
Cumulative dividends payable     15.00%                
Series D-1 Preferred Stock [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Preferred stock, shares authorized     5,134                
Preferred stock, shares issued     4,615                
Preferred stock, shares outstanding     4,615                
Shares converted to common stock     16                
Series D-2 Preferred Stock [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Preferred stock, shares authorized     10,868                
Series C-2 Warrants [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Total value of the embedded derivative       9,051,000              
Embedded Derivatives of accrued dividends payable        3,785,000              
Mandatory exercise of warrants upon achievement of the Preclinical Milestone 7,452,000                    
Mandatory exercise of warrants upon achievement of the Clinical milestone 3,194,000                    
Exercise Price Series D2 Warrants Preferred   $ 1,000                  
Securities Purchase Agreement (Additional Textual) [Abstract]                      
Derivative liabilities        3,785,000              
Series C-2 Warrants [Member] | Maximum [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Increased number of warrants 10,646                    
Series C-2 Warrants [Member] | Minimum [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Increased number of warrants 10,268                    
Series D-1 Warrants [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Total value of the embedded derivative     0 2,539,000              
Embedded Derivatives of accrued dividends payable        2,539,000              
Securities Purchase Agreement (Additional Textual) [Abstract]                      
Derivative liabilities        2,539,000              
Series D-2 Warrants [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Embedded Derivatives of accrued dividends payable        5,266,000              
Securities Purchase Agreement (Additional Textual) [Abstract]                      
Derivative liabilities        5,266,000              
Series C-1 Convertible Preferred Stock [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Aggregate of common shares of company   5,134                  
Preferred stock, par value                     $ 0.0001
Preferred stock, par value     $ 0.0001                
Preferred stock, shares authorized     11,000                
Preferred stock, shares issued     5,792                
Preferred stock, shares outstanding     5,792                
Series C-11 Preferred charged to general and administrative expense     5,792,000                
Series D-1 Convertible Preferred Stock [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Aggregate of common shares of company   5,134                  
Preferred stock, par value                     $ 0.0001
Series C-1 Preferred [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Preferred stock, par value                     $ 0.0001
Shares of Series C1 Preferred into common stock     340,851,000                
Preferred stock, shares authorized     11,000                
Preferred stock, shares issued     5,792 5,043             5,134
Number of preferred stock considered for dividends     84 74              
Dividend per shares       $ 0.014              
Preferred stock, shares outstanding     5,792 5,043              
Preferred stock, shares issued upon conversion of warrants     31,000 588,000              
Shares converted to common stock     18,000,000                
Accrued dividends on the Series C-11 Preferred     84,000 74,000              
Securities Purchase Agreement (Additional Textual) [Abstract]                      
Shares of Series C1 Preferred into common stock     340,851,000                
Series C-2 Preferred [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Preferred stock, shares authorized     22,000                
Preferred stock, shares issued     500                
Warrant, net proceeds     500,000                
Proceeds from warrants, shares     500                
Preferred stock, shares outstanding     500                
Series D-1 preferred
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Preferred stock, par value     $ 0.0001 $ 0.0001              
Shares of Series C1 Preferred into common stock     983,419,000                
Preferred stock, shares authorized     5,134                
Preferred stock, shares issued     4,615                
Preferred stock, shares outstanding     4,615                
Series C-11 Preferred charged to general and administrative expense     4,615,000                
Securities Purchase Agreement (Additional Textual) [Abstract]                      
Shares of Series C1 Preferred into common stock     983,419,000                
Series D-2 Preferred [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Preferred stock, shares authorized     10,868                
Common Stock [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Aggregate of common shares of company   289,704                  
Series C-1 Preferred Stock [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Preferred stock, shares authorized     11,000                
Preferred stock, shares issued     5,793 5,043              
Preferred stock, shares outstanding     5,793 5,043              
Series C-2 Convertible Preferred Stock [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Number of warrants series C2 to be purchased   10,268                  
Preferred stock, par value     $ 0.0001 $ 0.0001             $ 0.0001
Preferred stock, shares authorized     22,000 22,000              
Preferred stock, shares issued     500                 
Preferred stock, shares outstanding     500                 
Series C-11 Preferred charged to general and administrative expense     $ 500,000                
Series D-2 Convertible Preferred Stock [Member]
                     
Securities Purchase Agreement (Textual) [Abstract]                      
Preferred stock, par value                     $ 0.0001